norliqva

Generic: amlodipine

Labeler: cmp pharma, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name norliqva
Generic Name amlodipine
Labeler cmp pharma, inc.
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

amlodipine 1 mg/mL

Manufacturer
CMP Pharma, Inc.

Identifiers & Regulatory

Product NDC 46287-035
Product ID 46287-035_63a6bb49-fb68-4351-be5f-a6b6e8f6b540
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA214439
Listing Expiration 2026-12-31
Marketing Start 2022-04-15

Pharmacologic Class

Established (EPC)
dihydropyridine calcium channel blocker [epc] calcium channel blocker [epc]
Mechanism of Action
calcium channel antagonists [moa] cytochrome p450 3a inhibitors [moa]
Chemical Structure
dihydropyridines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 46287035
Hyphenated Format 46287-035

Supplemental Identifiers

RxCUI
2599173 2599179
UNII
1J444QC288
NUI
N0000000069 N0000175421 N0000175566 M0006414 N0000190114

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name norliqva (source: ndc)
Generic Name amlodipine (source: ndc)
Application Number NDA214439 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1 mg/mL
source: ndc
Packaging
  • 150 mL in 1 BOTTLE (46287-035-15)
source: ndc

Packages (1)

Ingredients (1)

amlodipine (1 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "63a6bb49-fb68-4351-be5f-a6b6e8f6b540", "openfda": {"nui": ["N0000000069", "N0000175421", "N0000175566", "M0006414", "N0000190114"], "unii": ["1J444QC288"], "rxcui": ["2599173", "2599179"], "spl_set_id": ["c1730a51-4383-4c61-a9a1-7e1326bd0abe"], "pharm_class_cs": ["Dihydropyridines [CS]"], "pharm_class_epc": ["Dihydropyridine Calcium Channel Blocker [EPC]", "Calcium Channel Blocker [EPC]"], "pharm_class_moa": ["Calcium Channel Antagonists [MoA]", "Cytochrome P450 3A Inhibitors [MoA]"], "manufacturer_name": ["CMP Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "150 mL in 1 BOTTLE (46287-035-15)", "package_ndc": "46287-035-15", "marketing_start_date": "20220415"}], "brand_name": "NORLIQVA", "product_id": "46287-035_63a6bb49-fb68-4351-be5f-a6b6e8f6b540", "dosage_form": "SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "46287-035", "generic_name": "amlodipine", "labeler_name": "CMP Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NORLIQVA", "active_ingredients": [{"name": "AMLODIPINE", "strength": "1 mg/mL"}], "application_number": "NDA214439", "marketing_category": "NDA", "marketing_start_date": "20220415", "listing_expiration_date": "20261231"}